Does NAD+ Decline With Age and What Can You Do About It?

Yes. NAD+ (nicotinamide adenine dinucleotide) declines with age in humans, a decline that has been documented across multiple tissues and research contexts. NAD+ is a coenzyme present in every living cell, required for cellular energy production, DNA repair, and the activity of sirtuins, proteins involved in cellular stress response and healthy aging. Nicotinamide Riboside (NR) is the most studied and well-characterized NAD+ precursor available as a supplement, and clinical research has confirmed that oral NR supplementation raises blood NAD+ levels in healthy middle-aged and older adults at doses of 500 mg per day.

What NAD+ is and why it matters

NAD+ is a coenzyme found in every cell in the body. It plays a central role in the metabolic pathways that convert nutrients into ATP (cellular energy), serves as a required cofactor for the enzymes that repair DNA damage, and activates sirtuins, a family of proteins that help regulate cellular stress responses and longevity pathways. Without adequate NAD+, cellular energy production and repair processes slow. This is why NAD+ has attracted significant research attention as a target for healthy aging interventions.

Research published in Nutrients via the National Institutes of Health documents that NAD+ bioavailability declines in animals and in humans during normal aging and notes that high cellular NAD+ levels promote metabolic and mitochondrial health. The decline begins measurably in the 30s and continues through subsequent decades.

Why NR is the most studied precursor

The body cannot efficiently absorb NAD+ directly from supplements because the molecule is too large to enter cells intact. Supplementation works by providing precursors: smaller molecules the body converts into NAD+ inside cells. Several precursors exist, including nicotinamide (NAM), nicotinic acid (niacin), and nicotinamide mononucleotide (NMN). NR stands out because it is readily taken up by cells and acts as a direct vitamin precursor for NAD+ synthesis, and because it is the form with the longest clinical research track record.

A landmark clinical study published in Nature Communications via the National Institutes of Health was the first to demonstrate that chronic NR supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. The study noted that NAD+ can be synthesized de novo from tryptophan, but that most cells rely on a salvage pathway for regenerating NAD+ that requires dietary precursors. NR enters this salvage pathway directly.

The research on NR has also addressed the limitations of other precursors: nicotinic acid is associated with undesirable flushing at therapeutic doses, and nicotinamide does not reliably activate sirtuins and may even inhibit them at higher doses. NR bypasses both of these limitations, which is why it has become the form most used in clinical research on NAD+ boosting in humans.

"I don't want to keep losing and losing and losing. I want the goals to be: what can I gain?"

— Dr. Tosin Odunsi, MD, MPH, FACOG, Obstetrics and Gynecology Physician

What the clinical research shows at 500 mg

The NR dose used across multiple clinical studies is 500 mg per day, often taken once or twice daily. A 12-week double-blind, randomized, placebo-controlled pilot study published in Alzheimer's and Dementia via the National Institutes of Health found that blood NAD+ increased significantly with NR supplementation at 500 mg twice daily compared with placebo, with no serious adverse effects. Blood NAD+ levels more than doubled in the NR group during the 12-week intervention. The study also noted a modest increase in delayed recall memory in the NR group.

Consistency of this NAD+ elevation has been documented across multiple studies. The clinical picture is clear: NR at 500 mg daily is safe, well-tolerated, and reliably raises blood NAD+ levels in healthy adults.

Why this matters specifically for women in the 35-55 window

The perimenopausal transition involves declining estrogen, which has its own effects on brain energy metabolism and cellular function. NAD+ decline compounds this: the cellular energy machinery is being asked to maintain function with both declining estrogen support and declining NAD+ availability. Addressing NAD+ during this window, rather than waiting for symptoms to progress, is consistent with the preventive framing that the research increasingly supports.

Research also links NAD+ to the same sirtuin activity that regulates cellular stress response and DNA repair, both of which become increasingly relevant as women move through the 40s. Supporting NAD+ levels during the perimenopausal and early postmenopausal window is a genuinely upstream intervention in healthy aging biology.

"She is passionate about whole-body wellness that honors both faith and science. NAD+ reflects that: rigorous research, clean formulation, and a genuine purpose."

— Amy Suzanne Upchurch, Founder and CEO of Pink Stork

Pink Stork NAD+ formulation

Pink Stork's our 500 mg Nicotinamide Riboside supplement provides exactly 500 mg of NR per capsule, the dose used across the clinical research, formulated without resveratrol for optimal NR bioavailability.† The product is vegan, non-GMO, gluten-free, made in the USA, and third-party tested in cGMP-certified laboratories. It is packaged in UV-protected bottles to preserve NR stability.

For women who want to address the perimenopausal cognitive picture more comprehensively, pairing NAD+ with our unflavored creatine for women supports both the NAD+-dependent cellular energy pathways and the phosphocreatine-ATP system that working memory draws on.†

For the full explanation of why brain fog peaks in perimenopause: Why Does Brain Fog Get Worse in Perimenopause?

For research-backed lifestyle habits alongside supplementation: What Actually Helps With Brain Fog in Women Over 35?

Pink Stork NAD+ is available at Target, Walmart, and CVS, with 50,000+ verified Amazon reviews across the brand.

Frequently asked questions

Does NAD+ really decline with age?

Yes. Multiple studies in humans and animal models have documented that NAD+ bioavailability declines during normal aging. The decline is measurable across tissues and is associated with the reduction in mitochondrial function and cellular repair capacity that accompanies aging.

What is Nicotinamide Riboside (NR)?

NR is a form of vitamin B3 that acts as a direct precursor to NAD+ in the cellular salvage pathway. It is readily taken up by cells and efficiently converted to NAD+. It is the most clinically studied NAD+ precursor for human supplementation and has the longest safety track record among NAD+ precursor forms.

How much NR do I need to raise NAD+ levels?

Clinical studies documenting significant NAD+ elevation use doses of 500 mg per day (taken once or twice daily). This is the dose supported by the research, and it is the dose Pink Stork NAD+ provides per capsule. Higher doses have been studied in some contexts but do not necessarily produce proportionally greater benefits for general wellness goals.

How long does NR take to raise NAD+ levels?

Clinical research shows meaningful NAD+ elevation within the first few weeks of consistent supplementation, with the elevation sustained throughout the supplementation period. Unlike creatine, which builds up over four to six weeks, NR's effect on blood NAD+ is relatively rapid but requires consistent daily dosing to maintain.

Is NAD+ supplementation safe long-term?

The clinical research to date documents good tolerability at 500 mg per day, with no serious adverse effects in multiple studies. NR is a form of vitamin B3, a nutrient the body uses routinely. As with any supplement, consult your healthcare provider, particularly if you are pregnant, breastfeeding, or managing a medical condition.

What is the difference between NR and NMN?

Both NR and NMN (nicotinamide mononucleotide) are NAD+ precursors. NR has a longer clinical research track record in humans, with more studies documenting safety and NAD+ elevation at defined doses. NMN has shown promising results in more recent studies but has fewer completed human clinical trials to date. Both appear to raise NAD+ levels, but NR is the better-characterized option for most supplementation contexts.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement, especially during pregnancy, breastfeeding, or while managing a medical condition. Keep out of reach of children.